Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Delivery
Return to: PBR Home | Drug Research | Drug Delivery

Drug Delivery

Eidos Therapeutics raises $64m for transthyretin amyloidosis therapy Eidos Therapeutics has completed $64m in Series B funding to support phase 2 clinical trials of AG10, a best-in-class therapy for transthyretin amyloidosis, and ongoing preparation for phase 3 clinical trials.
Drug Research > Drug Delivery > News
Biogen to acquire Pfizer’s schizophrenia drug for up to $590m By PBR Staff Writer
Biogen has agreed to buy Pfizer's investigational schizophrenia drug, PF-04958242, in a deal worth about $590m.
Drug Research > Drug Delivery > News JW Therapeutics secures $90m in new funding Clinical stage biopharmaceutical firm JW Therapeutics has secured $90m Series A financing from a consortium led by Temasek, Sequoia Capital China, and YuanMing Capital.
Drug Research > Drug Delivery > News
See more Drug Delivery news

Latest Drug Delivery News and Insight

View all Drug Delivery news or find news targeted to your interests
What's Hot at VFE2018 Softigel by Procaps
At this moment, what´s moving market growth are basically 3 aspects: - Aging population, were we see each day that senior consumers do not want to be defined by their age and wish to maintain their same active Lifestyle. - The FITNESS move, with consumers who are in search of preventive measures, instead of reactive measures in order to avoid future health problems. - And SELF-CARE: Since consumers are everyday more concerned with their wellbeing, new and more specialized Supplements need to be developed.
Drug Research > Drug Delivery > Press Releases
Innovation that leads to transformation: Join us during CPhI and live the Softigel experience!
Softigel by Procaps will be attending CPhi North America´s second edition once again, our team of experts will be delighted to sit with you, discuss mutual opportunities and live the Softigel experience.
Drug Research > Drug Delivery > Press Releases
Gel Technologies (Unigel, Gummygels, Chewgels, gtabs, versagel)
At Softigel we offer much more than traditional softgels, including everything from a single unit dosage form, to multiple delivery systems in a single dose.
Drug Research > Drug Delivery > Products
Eidos Therapeutics raises $64m for transthyretin amyloidosis therapy
Eidos Therapeutics has completed $64m in Series B funding to support phase 2 clinical trials of AG10, a best-in-class therapy for transthyretin amyloidosis, and ongoing preparation for phase 3 clinical trials.
Drug Research > Drug Delivery > News
Softgel Derivations
Twist-off Capsules A soft gelatin Soft gelatin capsules with twist-off caps enable access to a measured dose for topical and oral applications.
Drug Research > Drug Delivery > Products
Other Softigel Technology
Hard Gelatin Capsules: Capsules in which the shell is made up by two pieces: A body and a cap containing either a blend of powders or liquid fill formulations. The formulator is able to prepare products that have the desired release characteristics, a rapid, controlled or modified release. Hard capsules can be filled with formulations that have a wide range of physical properties, from dry solids to non-aqueous solutions.
Drug Research > Drug Delivery > Products
Omega-3
Softigel is dedicated to the research, development and manufacture of different Omega-3 extracts from fish oils from the Pacific Ocean. Our cutting-edge molecular distillation facility allows us to create an expanded line of products rich in EPA and DHA. Softigel formulates, manufactures and markets exceptional Rx, supplement, and nutritional products containing Omega-3 to help prevent and alleviate some of today’s top health concerns.
Drug Research > Drug Delivery > Products
Hormone Replacement Therapy and Birth Control
The use of hormones in hormone replacement therapies, as well as in birth control, demands very strict control to guarantee the exact dosage and balance within the organism. With our specialized and dedicated facilities for handling these special substances, our human talent is constantly being trained to maintain the confidence in our pharmaceutical specialties produced under the highest standards and very controlled specifications.
Drug Research > Drug Delivery > Products
View all Drug Delivery news or find news targeted to your interests